CA1339340C - Methode pour la detection et le traitement de tumeurs - Google Patents

Methode pour la detection et le traitement de tumeurs

Info

Publication number
CA1339340C
CA1339340C CA 598419 CA598419A CA1339340C CA 1339340 C CA1339340 C CA 1339340C CA 598419 CA598419 CA 598419 CA 598419 A CA598419 A CA 598419A CA 1339340 C CA1339340 C CA 1339340C
Authority
CA
Canada
Prior art keywords
immunoglobulin
tumor
fragment
agent
site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 598419
Other languages
English (en)
Inventor
Faina Shtern
Ban An Khaw
H. William Strauss
Robert H. Rubin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Priority to CA 598419 priority Critical patent/CA1339340C/fr
Application granted granted Critical
Publication of CA1339340C publication Critical patent/CA1339340C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA 598419 1989-05-02 1989-05-02 Methode pour la detection et le traitement de tumeurs Expired - Fee Related CA1339340C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 598419 CA1339340C (fr) 1989-05-02 1989-05-02 Methode pour la detection et le traitement de tumeurs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 598419 CA1339340C (fr) 1989-05-02 1989-05-02 Methode pour la detection et le traitement de tumeurs

Publications (1)

Publication Number Publication Date
CA1339340C true CA1339340C (fr) 1997-08-19

Family

ID=4139991

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 598419 Expired - Fee Related CA1339340C (fr) 1989-05-02 1989-05-02 Methode pour la detection et le traitement de tumeurs

Country Status (1)

Country Link
CA (1) CA1339340C (fr)

Similar Documents

Publication Publication Date Title
JP2810230B2 (ja) 感染性及び炎症性病変の検出及び治療のためのキメラ抗体
Becker et al. The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions
Zalutsky et al. Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies
US4925648A (en) Detection and treatment of infectious and inflammatory lesions
DE69215870T2 (de) Feststellung kardiovaskulärer läsionen
Hnatowich Recent developments in the radiolabeling of antibodies with iodine, indium, and technetium
US5363846A (en) Method for the diagnosis and treatment of inflammation
US5059413A (en) Scintigraphic monitoring of immunotoxins using radionuclides and heterobifunctional chelators
US5439665A (en) Detection and treatment of infectious and inflammatory lesions
Andrew et al. A comparison of iodine and indium labelled anti CEA intact antibody, F (ab) 2 and Fab fragments by imaging tumour xenografts
US5200178A (en) Method for tumor detection
US5277894A (en) Method for tumor detection and treatment
CA2113578A1 (fr) Composes trifonctionnels specifiques de cellules multiresistantes
WO1994004189A1 (fr) Anticorps/radio-isotope conjugues de diagnostic et/ou therapie de tumeurs
AU597032B2 (en) Method for the diagnosis and treatment of inflammation
CA1339340C (fr) Methode pour la detection et le traitement de tumeurs
Greager et al. Localization of human sarcoma with radiolabeled monoclonal antibody: A preliminary study
Vacca et al. Imaging of human leukemic T‐Cell Xenografts in nude mice by radiolabeled monoclonal antibodies and F (ab') 2 fragments
US5840272A (en) Imaging infectious foci with human IgM 16.88
USRE35152E (en) Method for the diagnosis and treatment of inflammation
Dunk et al. In vitro and in vivo tumour localisation with a monoclonal antibody directed against a membrane antigen on the human hepatocellular carcinoma cell line PLC/PRF/5
CA1338982C (fr) Detection de lesions infectieuses et inflammatoires a l'aide de conjugues anticorps anti-leucocytes
Hailu Studies on the potential of radiolabeled MAb174H64 in the detection and radioimmunoscintigraphy of squamous cell carcinoma (SCC) and the preliminary characterization of the SCC associated antigen

Legal Events

Date Code Title Description
MKLA Lapsed